Defence Therapeutics (XCNQ:DTC) Total Liabilities : C$2.96 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics Total Liabilities?

Defence Therapeutics's Total Liabilities for the quarter that ended in Dec. 2023 was C$2.96 Mil.

Defence Therapeutics's quarterly Total Liabilities increased from Mar. 2023 (C$1.82 Mil) to Sep. 2023 (C$2.03 Mil) and increased from Sep. 2023 (C$2.03 Mil) to Dec. 2023 (C$2.96 Mil).

Defence Therapeutics's annual Total Liabilities increased from Jun. 2020 (C$0.05 Mil) to Jun. 2021 (C$0.12 Mil) and increased from Jun. 2021 (C$0.12 Mil) to Jun. 2022 (C$1.11 Mil).

Defence Therapeutics Total Liabilities Historical Data

The historical data trend for Defence Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics Total Liabilities Chart

Defence Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

Total Liabilities

0.05

0.12

1.11

Defence Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial										1.23	2.55	1.82	2.03	2.96

Defence Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Defence Therapeutics's Total Liabilities for the fiscal year that ended in Jun. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.107	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1.11

Total Liabilities	=	Total Assets (A: Jun. 2022 )	-	Total Equity (A: Jun. 2022 )
	=	0.72	-	-0.388
	=	1.11

Defence Therapeutics's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.942	+	(0.023	+	-0.0010000000000002
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.96

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	0.669	-	-2.295
	=	2.96

Defence Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Defence Therapeutics (XCNQ:DTC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (XCNQ:DTC) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

DTCFF:USA DTC:Germany

Address

200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6

Website

https://www.defencetherapeutics.com

Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.

Executives

Sarkis Meterissian

Director